• 디지털융복합연구
• /
• 제15권3호
• /
• pp.39-46
• /
• 2017

본 연구의 목적은 우리나라에서 인터넷 중독 정책에서 나타나는 문제점에 대해서 고찰하고, 융합적 담론 구조에 의한 합리적 국가 정책의 전달체계를 모색하는 데 있다. 이를 위해 문헌연구를 통해 신제도론적 입장에서 현황을 분석하고 또 새로운 대안을 모색했다. 현재 우리나라에는 각 부처간 서로 다른 이해관계 때문에 정부 부처간, 그리고 정부, 기업, 시민사회간 다양한 갈등양상이 전개되는 것으로 나타났다. 신제도론 입장에서는 현재의 중앙정부가 주체가 된 정책 시스템을 향후 지방정부로 이전시키는 한편, 정부가 독점한 주도권을 정부, 기업, 시민사회가 함께 공유하여 거버넌스 형태로 운영하는 것이 최선인 것으로 도출되었다. 10개 중앙정부 협의체 형식의 국가시스템이 아니라 주민생활권 단위의 광역지방정부가 지역공동체 내의 기업, 학교, 시민사회 등과 협력하여 정책을 추진하는 것이다. 이 융합 모델은 현재의 부처간 고착화된 경쟁 구조 때문에 발생하는 갈등을 넘어 중독으로 인해 고통받는 주민에게 더 유익한 대안이 될 것이다. 또한 향후 지역공동체 내에서 정신건강 서비스의 전달체계 연구의 단초가 되기를 기대한다.

• 보건행정학회지
• /
• 제17권4호
• /
• pp.1-30
• /
• 2007

This study aims to analyze the policy change which is caused by conflicts between interest groups when the Separation of the Prescribing from the Dispensing of Drugs (SPDD) was enforced. With the theory of New Institutionalism, the reason why the policy was to be changed can be explained by the concept of property right and transaction cost. As the government did not consider the change of property right and transaction cost between actors before introducing new institution, it was hard to adapt the SPDD. Though, under the established institution, the institutional change can cause the alteration in property right and transaction cost, government just focused on the new institution's execution. Therefore, the group which suffers the loss could not accommodate to the change of institution. For this reason, the adaptation of SPDD also caused huge conflicts between doctors and pharmacists. Then, this research shows that the reason why they conflict to the some issues in the content of PSPDD and why the issues was changed with the property right and transaction cost.

• 보건행정학회지
• /
• 제21권1호
• /
• pp.132-157
• /
• 2011

The purpose of this article is to examine the cause of policy non-compliance in the case of pharmaceutical rebates from the perspective of rational choice institutionalism. In Korea, there have been rebates practices between pharmaceutical companies and hospitals since the introduction of the Actual Remuneration System for insured medicine in 1999. The government has chosen the policy means of punishment to eliminate pharmaceutical rebates but the illegal practices are still widespread. Institution in rational choice institutionalism usually reflects the incentives and preferences of actors, and the Actual Remuneration System has resulted in a the lack of procedures to ensure savings on drug expenditures. Pharmaceutical rebates are the product of the institutions which reflect their incentives: the Actual Remuneration System, the current pricing policy for generic drugs, the drug distribution system, and so on. In the end, the problem of the rebates is the consequence of policy non-compliance as actors' rational choice because their incentives lead to opportunistic behaviors. We should therefore understand the incentive structure of policy stakeholders, which is derived from the view of new institutionalism; also, the newly designed Korean drug pricing policy reform must be compatible with the incentive structure.